Different scaling and root planing strategies in Turkish patients with aggressive periodontitis: A randomized controlled clinical trial

Dilek Mamaklıoğlu 1, Maribasappa Karched 2, Leyla Kuru 3, Bahar Kuru 4, Sirkka Asikainen 2 5, Başak Doğan 3

Affiliations

05 January 2022

-

doi: 10.1111/idh.12592

Abstract

Objectives: The aim of this study was to compare clinical, cytokine and microbiological responses after quadrant-based scaling and root planing (Q-SRP), full-mouth SRP (FM-SRP) and full-mouth disinfection (FMD) in patients with generalized aggressive periodontitis (GAgP), which is currently termed as generalized stage-III and grade-C periodontitis.

Methods: Forty-two patients with GAgP were randomly assigned into groups as Q-SRP, FM-SRP or FMD with chlorhexidine. Clinical parameters were recorded, and gingival crevicular fluid (GCF) and subgingival plaque samples were collected at baseline, 3 and 6 months after treatment. GCF levels of interleukin (IL)-1β and IL-17 were analysed using ELISA. Quantities of six bacterial species were determined using qPCR.

Results: Clinical parameters improved significantly in all groups at 3 and 6 months (p < 0.05). Percentage of sites with probing depth >6 mm was lower in the FMD than Q-SRP group at 3 and 6 months (p < 0.05). FMD showed significantly higher percentage of pocket closure compared with Q-SRP and FM-SRP at both 3 and 6 months after treatment (p < 0.05). The IL-1β levels decreased only in the FMD group (p < 0.05), whereas no changes were found in IL-17 levels in any group. The levels of five out of six bacterial species decreased at 3 and/or 6 months only in the FMD group (p < 0.05).

Conclusions: The FMD treatment appears to offer superior outcome than Q-SRP and could be the first choice for patients with GAgP.

Keywords: aggressive periodontitis; bacteria; interleukin-1 beta; interleukin-17; periodontal debridement.

Similar articles

Full-mouth disinfection effects on gingival fluid calprotectin, osteocalcin, and N-telopeptide of Type I collagen in severe periodontitis.

Afacan B, Çınarcık S, Gürkan A, Özdemir G, İlhan HA, Vural C, Köse T, Emingil G.J Periodontol. 2020 May;91(5):638-650. doi: 10.1002/JPER.19-0445. Epub 2020 Mar 14.PMID: 32023661 Clinical Trial.

The Effects of Diode Laser Therapy as an Adjunct to Scaling and Root Planing in the Treatment of Aggressive Periodontitis: A 1-Year Randomized Controlled Clinical Trial.

Matarese G, Ramaglia L, Cicciù M, Cordasco G, Isola G.Photomed Laser Surg. 2017 Dec;35(12):702-709. doi: 10.1089/pho.2017.4288. Epub 2017 Sep 14.PMID: 28945145 Clinical Trial.

Comparison of full-mouth disinfection and quadrant-wise scaling in the treatment of adult chronic periodontitis: a systematic review and meta-analysis.

Fang H, Han M, Li QL, Cao CY, Xia R, Zhang ZH.J Periodontal Res. 2016 Aug;51(4):417-30. doi: 10.1111/jre.12326. Epub 2015 Oct 19.PMID: 26477533 Review.

Pre- and post-treatment experiences of fear, anxiety, and pain among chronic periodontitis patients treated by scaling and root planing per quadrant versus one-stage full-mouth disinfection: a 6-month randomized controlled clinical trial.

Santuchi CC, Cortelli SC, Cortelli JR, Cota LO, Alencar CO, Costa FO.J Clin Periodontol. 2015 Nov;42(11):1024-31. doi: 10.1111/jcpe.12472. Epub 2015 Nov 14.PMID: 26461465 Clinical Trial.

Efficacy of scaling and root planing with and without adjunct antimicrobial photodynamic therapy on the expression of cytokines in the gingival crevicular fluid of patients with periodontitis: A systematic review.

Kellesarian SV, Malignaggi VR, Abduljabbar T, Vohra F, Malmstrom H, Romanos GE, Javed F.Photodiagnosis Photodyn Ther. 2016 Dec;16:76-84. doi: 10.1016/j.pdpdt.2016.08.009. Epub 2016 Sep 5.PMID: 27609013 Review.

KMEL References

https://pubmed.ncbi.nlm.nih.gov/

References

  1.  
    1. Armitage GC. Development of a classification system for periodontal diseases and conditions. Ann Periodontol. 1999;4:1-6. doi:10.1902/annals.1999.4.1.1
  2.  
    1. Papapanou PN, Sanz M, Buduneli N, et al. Periodontitis: consensus report of workgroup 2 of the 2017 world workshop on the classification of periodontal and peri-implant diseases and conditions. J Clin Periodontol. 2018;89(Suppl 1):S173-S182. doi:10.1002/JPER.17-0721
  3.  
    1. Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: framework and proposal of a new classification and case definition. J Periodontol. 2018;89(Suppl 1):S159-S172. doi:10.1002/JPER.18-0006
  4.  
    1. Gomes EWB, Casarin M, Martins TM, da Silva AF. Local delivery therapies as adjuvants to non-surgical periodontal treatment of periodontitis grade C: a systematic review. Clin Oral Investig. 2020;24:4213-4224. doi:10.1007/s00784-020-03631-8
  5.  
    1. Herrera D, Matesanz P, Martin C, Oud V, Feres M, Teughels W. Adjunctive effect of locally delivered antimicrobials in periodontitis therapy: a systematic review and meta-analysis. J Clin Periodontol. 2020;47(Suppl 22):239-256. doi:10.1111/jcpe.13230
  6.  
    1. Taiete T, Casati MZ, Ribeiro Edel P, Sallum EA, Nociti Junior FH, Casarin RC. Amoxicillin/metronidazole associated with nonsurgical therapy did not promote additional benefits in immunologic parameters in generalized aggressive periodontitis: A randomized controlled clinical trial. Quintessence Int. 2016;47:281-292. doi:10.3290/j.qi.a34723
  7.  
    1. Bechara Andere NMR, Dos Santos NCC, Araujo CF, et al. Evaluation of the local effect of nonsurgical periodontal treatment with and without systemic antibiotic and photodynamic therapy in generalized aggressive periodontitis. A randomized clinical trial. Photodiagnosis Photodyn Ther. 2018;24:115-120. doi:10.1016/j.pdpdt.2018.09.002
  8.  
    1. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109:309-318. doi:10.1179/2047773215Y.0000000030
  9.  
    1. Teughels W, Feres M, Oud V, Martin C, Matesanz P, Herrera D. Adjunctive effect of systemic antimicrobials in periodontitis therapy: a systematic review and meta-analysis. J Clin Periodontol. 2020;47(Suppl 22):257-281. doi:10.1111/jcpe.13264
  10.  
    1. Sanz M, Herrera D, Kebschull M, et al. Treatment of stage I-III periodontitis-The EFP S3 level clinical practice guideline. J Clin Periodontol. 2020;47(Suppl 22):4-60. doi:10.1111/jcpe.13290
  11.  
    1. De Soete M, Mongardini C, Peuwels M, et al. One-stage full-mouth disinfection. Long-term microbiological results analyzed by checkerboard DNA-DNA hybridization. J Periodontol. 2001;72:374-382. doi:10.1902/jop.2001.72.3.374
  12.  
    1. Mongardini C, van Steenberghe D, Dekeyser C, Quirynen M. One stage full- versus partial-mouth disinfection in the treatment of chronic adult or generalized early-onset periodontitis. I. Long-term clinical observations. J Periodontol. 1999;70:632-645. doi:10.1902/jop.1999.70.6.632
  13.  
    1. Araujo CF, Andere N, Castro Dos Santos NC, et al. Two different antibiotic protocols as adjuncts to one-stage full-mouth ultrasonic debridement to treat generalized aggressive periodontitis: a pilot randomized controlled clinical trial. J Periodontol. 2019;90:1431-1440. doi:10.1002/JPER.18-0399
  14.  
    1. Quirynen M, Bollen CM, Vandekerckhove BN, Dekeyser C, Papaioannou W, Eyssen H. Full- vs. partial-mouth disinfection in the treatment of periodontal infections: short-term clinical and microbiological observations. J Dent Res. 1995;74:1459-1467.
  15.  
    1. Quirynen M, De Soete M, Dierickx K, van Steenberghe D. The intra-oral translocation of periodontopathogens jeopardises the outcome of periodontal therapy. A review of the literature. J Clin Periodontol. 2001;28:499-507.
  16.  
    1. Haffajee AD, Cugini MA, Dibart S, Smith C, Kent RL Jr, Socransky SS. The effect of SRP on the clinical and microbiological parameters of periodontal diseases. J Clin Periodontol. 1997;24:324-334.
  17.  
    1. Teles RP, Gursky LC, Faveri M, et al. Relationships between subgingival microbiota and GCF biomarkers in generalized aggressive periodontitis. J Clin Periodontol. 2010;37:313-323. doi:10.1111/j.1600-051X.2010.01534.x
  18.  
    1. Quirynen M, Mongardini C, Pauwels M, Bollen CM, Van Eldere J, van Steenberghe D. One stage full- versus partial-mouth disinfection in the treatment of chronic adult or generalized early-onset periodontitis. II. Long-term impact on microbial load. J Periodontol. 1999;70:646-656. doi:10.1902/jop.1999.70.6.646
  19.  
    1. Fonseca DC, Cortelli JR, Cortelli SC, et al. Clinical and microbiologic evaluation of scaling and root planing per quadrant and one-stage full-mouth disinfection associated with azithromycin or chlorhexidine: a clinical randomized controlled trial. J Periodontol. 2015;86:1340-1351. doi:10.1902/jop.2015.150227
  20.  
    1. Fang H, Han M, Li QL, Cao CY, Xia R, Zhang ZH. Comparison of full-mouth disinfection and quadrant-wise scaling in the treatment of adult chronic periodontitis: a systematic review and meta-analysis. J Periodontal Res. 2016;51:417-430. doi:10.1111/jre.12326
  21.  
    1. Suvan J, Leira Y, Moreno Sancho FM, Graziani F, Derks J, Tomasi C. Subgingival instrumentation for treatment of periodontitis. A systematic review. J Clin Periodontol. 2020;47(Suppl 22):155-175. doi:10.1111/jcpe.13245
  22.  
    1. Haas AN, Silva-Boghossian CM, Colombo AP, et al. Predictors of clinical outcomes after periodontal treatment of aggressive periodontitis: 12-month randomized trial. Braz Oral Res. 2016;30: doi:10.1590/1807-3107BOR-2016
  23.  
    1. Aimetti M, Romano F, Guzzi N, Carnevale G. Full-mouth disinfection and systemic antimicrobial therapy in generalized aggressive periodontitis: a randomized, placebo-controlled trial. J Clin Periodontol. 2012;39:284-294. doi:10.1111/j.1600-051X.2011.01795.x
  24.  
    1. Casarin RC, Peloso Ribeiro ED, Sallum EA, Nociti FH Jr, Goncalves RB, Casati MZ. The combination of amoxicillin and metronidazole improves clinical and microbiologic results of one-stage, full-mouth, ultrasonic debridement in aggressive periodontitis treatment. J Periodontol. 2012;83:988-998. doi:10.1902/jop.2012.110513
  25.  
    1. do Vale HF, Casarin R Corrêa Viana, Taiete Tiago, et al. Full-mouth ultrasonic debridement associated with povidone iodine rinsing in GAgP treatment: a randomised clinical trial. Clin Oral Investig. 2016;20:141-150. doi:10.1007/s00784-015-1471-y
  26.  
    1. Andere N, Castro Dos Santos NC, Araujo CF, et al. Clarithromycin as an adjunct to one-stage full-mouth ultrasonic periodontal debridement in generalized aggressive periodontitis: a randomized controlled clinical trial. J Periodontol. 2017;88:1244-1252. doi:10.1902/jop.2017.170165
  27.  
    1. Grusovin MG, Bossini S, Calza S, et al. Clinical efficacy of Lactobacillus reuteri-containing lozenges in the supportive therapy of generalized periodontitis stage III and IV, grade C: 1-year results of a double-blind randomized placebo-controlled pilot study. Clin Oral Investig. 2020;24(6):2015-2024. doi:10.1007/s00784-019-03065-x
  28.  
    1. Moreira RM, Feres-Filho EJ. Comparison between full-mouth scaling and root planing and quadrant-wise basic therapy of aggressive periodontitis: 6-month clinical results. J Periodontol. 2007;78:1683-1688. doi:10.1902/jop.2007.060354
  29.  
    1. Montenegro SCL, Retamal-Valdes B, Bueno-Silva B, et al. Do patients with aggressive and chronic periodontitis exhibit specific differences in the subgingival microbial composition? A systematic review. J Periodontol. 2020;91:1503-1520. doi:10.1002/JPER.19-0586
  30.  
    1. Curtis MA, Diaz PI, Van Dyke TE. The role of the microbiota in periodontal disease. Periodontol. 2000;2020(83):14-25. doi:10.1111/prd.12296
  31.  
    1. Graves D. Cytokines that promote periodontal tissue destruction. J Periodontol. 2008;79:1585-1591. doi:10.1902/jop.2008.080183
  32.  
    1. Graves DT, Cochran D. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol. 2003;74:391-401. doi:10.1902/jop.2003.74.3.391
  33.  
    1. Seymour GJ, Gemmell E. Cytokines in periodontal disease: where to from here? Acta Odontol Scand. 2001;59:167-173. doi:10.1080/000163501750266765
  34.  
    1. Martins ES, Cesar-Neto JB, Albuquerque-Souza E, et al. One-year follow-up of the immune profile in serum and selected sites of generalized and localized aggressive periodontitis. Cytokine. 2019;116:27-37. doi:10.1016/j.cyto.2018.12.019
  35.  
    1. Romano F, Bongiovanni L, Bianco L, et al. Biomarker levels in gingival crevicular fluid of generalized aggressive periodontitis patients after non-surgical periodontal treatment. Clin Oral Investig. 2018;22(2):1083-1092. doi:10.1007/s00784-017-2192-1
  36.  
    1. Kanmaz B, Lappin DF, Nile CJ, Buduneli N. Effects of smoking on non-surgical periodontal therapy in patients with periodontitis stage III or IV, and grade C. J Periodontol. 2020;91:442-453. doi:10.1002/JPER.19-0141
  37.  
    1. Rosalem W, Rescala B, Teles RP, Fischer RG, Gustafsson A, Figueredo CM. Effect of non-surgical treatment on chronic and aggressive periodontitis: clinical, immunologic, and microbiologic findings. J Periodontol. 2011;82:979-989. doi:10.1902/jop.2011.100579
  38.  
    1. Miossec P, Kolls JK. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov. 2012;11:763-776. doi:10.1038/nrd3794
  39.  
    1. Tesmer LA, Lundy SK, Sarkar S, Fox DA. Th17 cells in human disease. Immunol Rev. 2008;223:87-113. doi:10.1111/j.1600-065X.2008.00628.x
  40.  
    1. Takahashi K, Azuma T, Motohira H, Kinane DF, Kitetsu S. The potential role of interleukin-17 in the immunopathology of periodontal disease. J Clin Periodontol. 2005;32:369-374. doi:10.1111/j.1600-051X.2005.00676.x
  41.  
    1. Yu JJ, Ruddy MJ, Wong GC, et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood. 2007;109:3794-3802. doi:10.1182/blood-2005-09-010116
  42.  
    1. Fossiez F, Djossou O, Chomarat P, et al. T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines. J Exp Med. 1996;183:2593-2603. doi:10.1084/jem.183.6.2593
  43.  
    1. Jovanovic DV, Di Battista JA, Martel-Pelletier J, et al. IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol. 1998;160:3513-3521.
  44.  
    1. Cifcibasi E, Koyuncuoglu C, Ciblak M, et al. Evaluation of local and systemic levels of interleukin-17, interleukin-23, and myeloperoxidase in response to periodontal therapy in patients with generalized aggressive periodontitis. Inflammation. 2015;38:1959-1968. doi:10.1007/s10753-015-0176-3
  45.  
    1. Swierkot K, Nonnenmacher CI, Mutters R, Flores-de-Jacoby L, Mengel R. One-stage full-mouth disinfection versus quadrant and full-mouth root planing. J Clin Periodontol. 2009;36:240-249. doi:10.1111/j.1600-051X.2008.01368.x
  46.  
    1. Dogan B, Chen J, Ciftlikli SY, et al. Occurrence and serotype distribution of Aggregatibacter actinomycetemcomitans in subjects without periodontitis in Turkey. Arch Oral Biol. 2016;61:125-129. doi:10.1016/j.archoralbio.2015.10.023
  47.  
    1. Silness J, Loe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand. 1964;22:121-135. doi:10.3109/00016356408993968
  48.  
    1. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand. 1963;21:533-551. doi:10.3109/00016356309011240
  49.  
    1. Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical periodontal therapy. I. Moderately advanced periodontitis. J Clin Periodontol. 1981;8:57-72.
  50.  
    1. Asikainen S, Dogan B, Turgut Z, Paster BJ, Bodur A, Oscarsson J. Specified species in gingival crevicular fluid predict bacterial diversity. PLoS One. 2010;5:e13589. doi:10.1371/journal.pone.0013589
  51.  
    1. Dogan B, Antinheimo J, Cetiner D, et al. Subgingival microflora in Turkish patients with periodontitis. J Periodontol. 2003;74:803-814. doi:10.1902/jop.2003.74.6.803
  52.  
    1. Kuru BE, Laleman I, Yalnizoglu T, Kuru L, Teughels W. The influence of a Bifidobacterium animalis probiotic on gingival health: a randomized controlled clinical trial. J Periodontol. 2017;88:1115-1123. doi:10.1902/jop.2017.170213
  53.  
    1. Karched M, Bhardwaj RG, Inbamani A, Asikainen S. Quantitation of biofilm and planktonic life forms of coexisting periodontal species. Anaerobe. 2015;35:13-20. doi:10.1016/j.anaerobe.2015.04.013
  54.  
    1. Ramirez V, Hach M, Lopez R. Definition of aggressive periodontitis in periodontal research. A systematic review. J Clin Periodontol. 2018;45:278-284. doi:10.1111/jcpe.12853
  55.  
    1. Fine DH, Patil AG, Loos BG. Classification and diagnosis of aggressive periodontitis. J Periodontol. 2018;89(Suppl 1):S103-S119. doi:10.1002/JPER.16-0712
  56.  
    1. Caton JG, Armitage G, Berglundh T, et al. A new classification scheme for periodontal and peri-implant diseases and conditions - introduction and key changes from the 1999 classification. J Periodontol. 2018;89(Suppl 1):S1-S8. doi:10.1002/JPER.18-0157
  57.  
    1. Haas AN, de Castro GD, Moreno T, et al. Azithromycin as an adjunctive treatment of aggressive periodontitis: 12-months randomized clinical trial. J Clin Periodontol. 2008;35:696-704. doi:10.1111/j.1600-051X.2008.01254.x
  58.  
    1. Sigusch BW, Guntsch A, Pfitzner A, Glockmann E. Enhanced root planing and systemic metronidazole administration improve clinical and microbiological outcomes in a two-step treatment procedure. J Periodontol. 2005;76:991-997. doi:10.1902/jop.2005.76.6.991
  59.  
    1. Graziani F, Karapetsa D, Mardas N, Leow N, Donos N. Surgical treatment of the residual periodontal pocket. Periodontol. 2000;2018(76):150-163. doi:10.1111/prd.12156
  60.  
    1. Čuk K, Povšič K, Milavec S, Seme K, Gašperšič R. Influence of adjunctive azithromycin on microbiological and clinical outcomes in periodontitis patients: 6-month results of randomized controlled clinical trial. BMC Oral Health. 2020;20:241. doi:10.1186/s12903-020-01209-0
  61.  
    1. Matuliene G, Pjetursson BE, Salvi GE, et al. Influence of residual pockets on progression of periodontitis and tooth loss: results after 11 years of maintenance. J Clin Periodontol. 2008;35:685-695. doi:10.1111/j.1600-051X.2008.01245.x
  62.  
    1. Gaffen SL, Hajishengallis G. A new inflammatory cytokine on the block: re-thinking periodontal disease and the Th1/Th2 paradigm in the context of Th17 cells and IL-17. J Dent Res. 2008;87:817-828. doi:10.1177/154405910808700908
  63.  
    1. Romano F, Del Buono W, Bianco L, et al. Gingival crevicular fluid cytokines in moderate and deep sites of stage III periodontitis patients in different rates of clinical progression. Biomedicines. 2020;8:515. doi:10.3390/biomedicines8110515
  64.  
    1. Al-Khureif AA, Mohamed BA, Siddiqui AZ, Khan AA, Divakar DD. Repeated application of photodynamic and antibiotic therapy as an adjunct to root surface debridement in patients with grade C and stage III or IV aggressive periodontitis. Photodiagnosis Photodyn Ther 2020;29:101610. doi:10.1016/j.pdpdt.2019.101610
  65.  
    1. Engebretson SP, Grbic JT, Singer R, Lamster IB. GCF IL-1β profiles in periodontal disease. J Clin Periodontol. 2002;29:48-53. doi:10.1034/j.1600-051x.2002.290108.x
  66.  
    1. Kinney JS, Morelli T, Oh M, et al. Crevicular fluid biomarkers and periodontal disease progression. J Clin Periodontol. 2014;41(2):113-120. doi:10.1111/jcpe.12194
  67.  
    1. Liston A, Carr EJ, Linterman MA. Shaping variation in the human immune system. Trends Immunol. 2016;37:637-646. doi:10.1016/j.it.2016.08.002
  68.  
    1. Mombelli A. Microbial colonization of the periodontal pocket and its significance for periodontal therapy. Periodontol. 2000;2018(76):85-96. doi:10.1111/prd.12147

Page Navigation